Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)

As the coronavirus disease 19 (COVID-19) global pandemic rages across the globe, the race to prevent and treat this deadly disease has led to the “off-label” repurposing of drugs such as hydroxychloroquine and lopinavir/ritonavir, which have the potential for unwanted QT-interval prolongation and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Giudicessi, John R., Noseworthy, Peter A., Friedman, Paul A., Ackerman, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mayo Foundation for Medical Education and Research 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141471/
https://www.ncbi.nlm.nih.gov/pubmed/32359771
http://dx.doi.org/10.1016/j.mayocp.2020.03.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141471/
https://www.ncbi.nlm.nih.gov/pubmed/32359771
http://dx.doi.org/10.1016/j.mayocp.2020.03.024

Ejemplares similares